Land: Irland
Sprache: Englisch
Quelle: HPRA (Health Products Regulatory Authority)
Clotrimazole
PCO Manufacturing Ltd.
G01AF02
Clotrimazole
500 milligram(s)
Pessary
Product not subject to medical prescription
clotrimazole
Authorised
2006-03-03
_ _ _ _ PACKAGE LEAFLET: INFORMATION FOR THE USER CANESTEN ® 500 MG PESSARY CLOTRIMAZOLE R EAD ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. – Always use this medicine exactly as described in this leaflet or as your pharmacist has told you. Keep this leaflet. You may need to read it again. – Ask your pharmacist if you need more information or advice. – If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See Section 4. – You must contact a doctor if your symptoms worsen or do not improve in 7 days. WHAT IS IN THIS LEAFLET 1. What is Canesten 500 mg Pessary and what is it used for 2. What you need to know before you use Canesten 500 mg Pessary 3. How to use Canesten 500 mg Pessary 4. Possible side effects 5. How to store Canesten 500 mg Pessary 6. Contents of the pack and other information 1. WHAT IS CANESTEN 500 MG PESSARY AND WHAT IS IT USED FOR Canesten 500 mg Pessary is a single application for the treatment of vaginal thrush. It is inserted into the vagina for the treatment at the site of infection. ONLY USE THIS PRODUCT IF YOU HAVE BEEN PREVIOUSLY DIAGNOSED BY YOUR DOCTOR AS HAVING VAGINAL THRUSH. The active substance in Canesten 500 mg Pessary is clotrimazole. Clotrimazole belongs to a group of medicines called azoles and is an antifungal agent which fights the cause of infections such as vaginal thrush. 2. WHAT YOU NEED TO KNOW BEFORE YOU USE CANESTEN 500 MG PESSARY DO NOT USE CANESTEN 500 MG PESSARY: • If you are allergic (hypersensitive) to clotrimazole or any of the other ingredients of Canesten 500 mg Pessary (listed in section 6). • During your period as it may be less effective. WARNINGS AND PRECAUTIONS: Talk to your doctor or pharmacist before using CANESTEN® 500 MG PESSARY You are unsure whether you have thrush or this is the first time you have had these symptoms. • You have had more than two infections of thrush in the last six mont Lesen Sie das vollständige Dokument
Health Products Regulatory Authority 13 April 2022 CRN00CVKD Page 1 of 2 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Canesten 500 mg Pessary. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each pessary contains 500mg clotrimazole. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Pessary. _Product imported from the UK and Greece:_ White, convex pessary marked 'BAYER' on one side and 'MU' on the other. 4 CLINICAL PARTICULARS As per PA1410/039/009 5 PHARMACOLOGICAL PROPERTIES As per PA1410/039/009 6 PHARMACEUTICAL PARTICULARS 6.1 LIST OF EXCIPIENTS Lactose monohydrate Microcrystalline cellulose Lactic acid Maize starch Crospovidone Calcium lactate pentahydrate Magnesium stearate Silica, colloidal anhydrous Hypromellose Product sourced from Greece also contain purified water. 6.2 INCOMPATIBILITIES Not applicable. 6.3 SHELF LIFE The shelf-life expiry date of this product is the date shown on the container and outer package of the product on the market in the country of origin. 6.4 SPECIAL PRECAUTIONS FOR STORAGE Do not store above 25 °C. 6.5 NATURE AND CONTENTS OF CONTAINER Each pessary is packed into a foil blister. The foil blister is enclosed in an over-labelled outer cardboard carton with a disposable applicator and patient information leaflet. Health Products Regulatory Authority 13 April 2022 CRN00CVKD Page 2 of 2 6.6 SPECIAL PRECAUTIONS FOR DISPOSAL OF A USED MEDICINAL PRODUCT OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCT AND OTHER HANDLING OF THE PRODUCT Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment. 7 PARALLEL PRODUCT AUTHORISATION HOLDER PCO Manufacturing Ltd. Unit 10, Ashbourne Business Park Rath Ashbourne Co. Meath Ireland 8 PARALLEL PRODUCT AUTHORISATION NUMBER PPA0465/048/002 9 DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisation: 03 March 2006 Last updated: February 2021 10 DATE Lesen Sie das vollständige Dokument